Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$43.54 USD
-1.68 (-3.72%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $43.54 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RVMD 43.54 -1.68(-3.72%)
Will RVMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RVMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVMD
Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade
Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect?
RVMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?
Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround
Revolution Medicines (RVMD) Loses -7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for RVMD
RVMD forms 180 Bullish Setup on September 18
Is RVMD primed for upward momentum? Upper Bollinger Band Walk shows up after declining 1.99%
RVMD forms Slingshot Bullish on September 16
Analysts Are Bullish on These Healthcare Stocks: Revolution Medicines (RVMD), Travere Therapeutics (TVTX)
Upper Bollinger Band Walk appears for RVMD after 0.75% move